Role of PDL1 as a prognostic marker in renal cell carcinoma: a prospective observational study in eastern India

BACKGROUND: Renal cell carcinoma (RCC) is one of the most common genitourinary malignancies. Programmed death ligand-1 (PDL1) is an immune checkpoint inhibitor, instrumental in ‘T cell escape’ of malignant cells. PDL1 has been shown to be associated with poor prognosis in multiple small studies. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Barun, Ghosh, Amlan, Datta, Chhanda, Pal, Dilip Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691662/
https://www.ncbi.nlm.nih.gov/pubmed/31447938
http://dx.doi.org/10.1177/1756287219868859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691662/
https://www.ncbi.nlm.nih.gov/pubmed/31447938
http://dx.doi.org/10.1177/1756287219868859

Ejemplares similares